HeartMate 3-a "Step" in the right direction.
作者信息
Alvarez Juglans, Rao Vivek
机构信息
Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada.
出版信息
J Thorac Dis. 2017 May;9(5):E457-E460. doi: 10.21037/jtd.2017.04.39.
Abstract
摘要
相似文献
1
HeartMate 3-a "Step" in the right direction.HeartMate 3——朝着正确方向迈出的“一步”。
J Thorac Dis. 2017 May;9(5):E457-E460. doi: 10.21037/jtd.2017.04.39.
2
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.左心室辅助装置植入术后的右心功能障碍：搏动性HeartMate I与轴流式HeartMate II装置的比较
Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.
3
Comparison of Hemodynamic Performance and Clinical Results with EVAHEART Versus HeartMate II.EVAHEART与HeartMate II的血流动力学性能及临床结果比较。
ASAIO J. 2017 Sep/Oct;63(5):562-567. doi: 10.1097/MAT.0000000000000530.
4
HeartMate left ventricular assist device for long-term circulatory support.HeartMate左心室辅助装置用于长期循环支持。
J Formos Med Assoc. 2000 Apr;99(4):336-40.
5
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.使用HeartMate II左心室辅助装置作为桥接至移植治疗可提高生存率并降低不良事件发生率。
Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.
6
Survival after left ventricular assist device with and without temporary right ventricular support.左心室辅助装置辅助治疗伴或不伴临时右心室支持的生存情况。
Ann Thorac Surg. 2013 Dec;96(6):2155-9. doi: 10.1016/j.athoracsur.2013.07.008. Epub 2013 Sep 12.
7
Transition from cardiopulmonary bypass to the HeartMate left ventricular assist device.从体外循环过渡到HeartMate左心室辅助装置。
Ann Thorac Surg. 1998 Mar;65(3):643-6. doi: 10.1016/s0003-4975(97)01353-2.
8
Two Years of Experience in the Implantation of Heartmate III.
Rev Port Cir Cardiotorac Vasc. 2017 Jul-Dec;24(3-4):120.
9
Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?与使用轴流HeartMate II的患者相比，使用离心流HeartMate 3或HeartWare左心室辅助装置的患者是否有更好的治疗效果？
Interact Cardiovasc Thorac Surg. 2019 Dec 1;29(6):844-851. doi: 10.1093/icvts/ivz202.
10
HeartMate left ventricular assist devices: a multigeneration of implanted blood pumps.
Artif Organs. 2001 May;25(5):422-6. doi: 10.1046/j.1525-1594.2001.06756.x.
引用本文的文献
1
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices.HeartMate 3左心室辅助装置介导的心脏逆向重构：与前代装置的比较。
ASAIO J. 2024 Dec 1;70(12):1060-1066. doi: 10.1097/MAT.0000000000002245. Epub 2024 May 28.
2
Hurdles to Cardioprotection in the Critically Ill.危重症患者的心脏保护障碍。
Int J Mol Sci. 2019 Aug 5;20(15):3823. doi: 10.3390/ijms20153823.
本文引用的文献
1
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.全磁悬浮循环泵用于治疗心力衰竭。
N Engl J Med. 2017 Feb 2;376(5):440-450. doi: 10.1056/NEJMoa1610426. Epub 2016 Nov 16.
2
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy.NHLBI REVIVE-IT 研究：在当前左心室辅助装置治疗的背景下了解其终止的原因。
J Heart Lung Transplant. 2016 Nov;35(11):1277-1283. doi: 10.1016/j.healun.2016.09.002. Epub 2016 Oct 6.
3
Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.在晚期心力衰竭患者中使用完全磁悬浮离心式连续流左心室辅助装置评估血管性血友病因子
J Heart Lung Transplant. 2016 Jul;35(7):860-7. doi: 10.1016/j.healun.2016.05.019. Epub 2016 May 31.
4
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.磁悬浮技术在使用HeartMate 3进行机械循环支持治疗的患者中的多中心研究（MOMENTUM 3）研究性器械豁免临床试验方案的临床试验设计与原理。
J Heart Lung Transplant. 2016 Apr;35(4):528-36. doi: 10.1016/j.healun.2016.01.021. Epub 2016 Jan 30.
5
Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.全磁悬浮左心室辅助系统治疗晚期心力衰竭：多中心研究。
J Am Coll Cardiol. 2015 Dec 15;66(23):2579-2589. doi: 10.1016/j.jacc.2015.09.083.
6
Seventh INTERMACS annual report: 15,000 patients and counting.国际机械循环辅助装置注册研究（INTERMACS）第七年度报告：15000例患者及仍在增加。
J Heart Lung Transplant. 2015 Dec;34(12):1495-504. doi: 10.1016/j.healun.2015.10.003. Epub 2015 Oct 8.
7
Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.环磷酸鸟苷水平升高与连续流左心室辅助装置：对胃肠道出血的影响
J Thorac Cardiovasc Surg. 2016 Jan;151(1):219-27. doi: 10.1016/j.jtcvs.2015.09.015. Epub 2015 Sep 18.
8
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.在门诊心力衰竭患者中左心室辅助装置与药物治疗的风险评估和比较效果：来自 ROADMAP 研究的结果。
J Am Coll Cardiol. 2015 Oct 20;66(16):1747-1761. doi: 10.1016/j.jacc.2015.07.075.
9
Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study.HeartMate II患者中降低抗血栓形成策略的安全性：美国TRACE研究的一年分析。
J Heart Lung Transplant. 2015 Dec;34(12):1542-8. doi: 10.1016/j.healun.2015.06.018. Epub 2015 Jul 4.
10
Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?†.术后血压是否会影响连续流左心室辅助装置植入术后主动脉瓣反流的发生？†
Eur J Cardiothorac Surg. 2016 Mar;49(3):788-94. doi: 10.1093/ejcts/ezv221. Epub 2015 Jun 23.
Zotero 插件